HM Payson & Co’s VIVEVE MED INC VIVE Stock Holding History

HM Payson & Co’s Portfolio VIVE Stock Details VIVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1	Closed	–	–	1176
2020 Q3	$0	Hold	1	–	–	﹤0.01%	1080
2020 Q2	$0	Hold	1	–	–	﹤0.01%	953
2020 Q1	$0	Hold	1	–	–	﹤0.01%	992
2019 Q4	$0	Sell	1 -6	-86%	-$171	﹤0.01%	984
2019 Q3	$0	Hold	7	–	–	﹤0.01%	991
2019 Q2	$3K	Buy	+7	New	+$3.8K	﹤0.01%	907

Other funds holding VIVE

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

HM Payson & Co's VIVE Position: Q4 2020 in Review

HM Payson & Co sold out of VIVEVE MED INC (VIVE) in Q4 2020, closing a stake of 1 share.

HM Payson & Co first reported a position in VIVE in Q2 2019 and held it in 6 quarters. The position peaked at $3K in Q2 2019. 9 funds tracked by Wall St. Rank hold VIVE as of Q4 2020.

HM Payson & Co reported no remaining VIVEVE MED INC position as of Q4 2020 after selling out during the quarter.
HM Payson & Co sold 1 VIVEVE MED INC share in Q4 2020.
HM Payson & Co first reported a position in VIVEVE MED INC in Q2 2019 and held it in 6 quarters.
HM Payson & Co's VIVEVE MED INC position peaked at $3K in Q2 2019.
9 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q4 2020.

Based on HM Payson & Co's 13F filing for Q4 2020, filed 10 Mar 2021.